Search Results for "first impressions"

Tom Caravela

Mastering the First Impression

Jan 29^th • 2 mins read

Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

May 17^th • 2 mins read

Tom Caravela

MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion

May 19^th • 2 mins read

Tom Caravela

10 Ways to Make an Impact on a Phone Interview

Apr 9^th • 1 min read

Tom Caravela

Resume Writing and Editing Tips for Pharma Professionals

Aug 8^th • 1 min read

Tom Caravela

Combatting the “Summer Slow Down" – MSL Job Search Tips for Slower Months

Jun 23^rd • 2 mins read

Tom Caravela

INTENTION: The Key to Achieving Your Goals

Jan 21^st • 1 min read

Tom Caravela

MSL People Skills: Top 10 Tips for Better Engagement

Apr 20^th • 8 mins read

Tom Caravela

Promotability: How to Land Your Next Promotion

May 5^th • 10 mins read

Bridget Rasmusson

Positioning Yourself to Become an MSL in 2022

Dec 21^st • 10 mins read

Tom Caravela

What to do When a Job Offer is Rescinded

Jul 20^th • 5 mins read

iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

May 16^th • 5 mins read

B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Apr 20^th • 8 mins read

Adela Rodriguez, Francis Esposito, Helena Oliveres, Ferran Torres and Joan Maurel

Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?

Feb 11^th • 3 mins read

Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Feb 22^nd • 10 mins read

Charles L. Bennett , Sumimasa Nagai , Andrew C. Bennett , Shamia Hoque , Chadi Nabhan , Martin W. Schoen , William J. Hrushesky , Stefano Luminari , Paul Ray , Paul R. Yarnold , Bart Witherspoon , Josh Riente , Laura Bobolts , John Brusk , Rebecca Tombles

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

Mar 12^th • 7 mins read

Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Sep 27^th • 1 min read

Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Nov 20^th • 12 mins read

Jorge J. García, Luis E. Raez, Daniel Rosas

A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementation

Aug 3^rd • 10 mins read

Carrie Printz

First person profile: William Sellers, MD

Nov 6^th • 2 mins read

Navigation

Results for 'first impressions'

Mastering the First Impression

Job Search Checklist for Aspiring Medical Science Liaisons

MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion

10 Ways to Make an Impact on a Phone Interview

Resume Writing and Editing Tips for Pharma Professionals

Combatting the “Summer Slow Down" – MSL Job Search Tips for Slower Months

INTENTION: The Key to Achieving Your Goals

MSL People Skills: Top 10 Tips for Better Engagement

Promotability: How to Land Your Next Promotion

Positioning Yourself to Become an MSL in 2022

What to do When a Job Offer is Rescinded

Transforming oncology: Five frontiers driving progress in cancer care

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementation

First person profile: William Sellers, MD

Related Topics

Navigation

Results for 'first impressions'

Mastering the First Impression

Job Search Checklist for Aspiring Medical Science Liaisons

MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion

10 Ways to Make an Impact on a Phone Interview

Resume Writing and Editing Tips for Pharma Professionals

Combatting the “Summer Slow Down"​ – MSL Job Search Tips for Slower Months

INTENTION: The Key to Achieving Your Goals

MSL People Skills: Top 10 Tips for Better Engagement

Promotability: How to Land Your Next Promotion

Positioning Yourself to Become an MSL in 2022

What to do When a Job Offer is Rescinded

Transforming oncology: Five frontiers driving progress in cancer care

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

A narrative review of biosimilars: a continued journey from the scientific evidence to practice implementation

First person profile: William Sellers, MD

Related Topics

Combatting the “Summer Slow Down" – MSL Job Search Tips for Slower Months